BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 31552045)

  • 1. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
    Mylvaganam G; Yanez AG; Maus M; Walker BD
    Front Immunol; 2019; 10():2109. PubMed ID: 31552045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.
    Yang H; Wallace Z; Dorrell L
    Front Immunol; 2018; 9():2861. PubMed ID: 30564246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Developing CAR T-Cell Therapy for HIV Cure.
    Qi J; Ding C; Jiang X; Gao Y
    Front Immunol; 2020; 11():361. PubMed ID: 32210965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options.
    Velu V; Shetty RD; Larsson M; Shankar EM
    Retrovirology; 2015 Feb; 12():14. PubMed ID: 25756928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
    Ollerton MT; Berger EA; Connick E; Burton GF
    J Virol; 2020 May; 94(10):. PubMed ID: 32161179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
    Ruiz A; Blanch-Lombarte O; Jimenez-Moyano E; Ouchi D; Mothe B; Peña R; Galvez C; Genescà M; Martinez-Picado J; Goulder P; Barnard R; Howell B; Clotet B; Prado JG
    Front Immunol; 2018; 9():3162. PubMed ID: 30723480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell exhaustion in HIV infection.
    Fenwick C; Joo V; Jacquier P; Noto A; Banga R; Perreau M; Pantaleo G
    Immunol Rev; 2019 Nov; 292(1):149-163. PubMed ID: 31883174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-Resistant and HIV-Specific CAR-Modified CD4
    Maldini CR; Gayout K; Leibman RS; Dopkin DL; Mills JP; Shan X; Glover JA; Riley JL
    Mol Ther; 2020 Jul; 28(7):1585-1599. PubMed ID: 32454027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.
    Sgadari C; Monini P; Tripiciano A; Picconi O; Casabianca A; Orlandi C; Moretti S; Francavilla V; Arancio A; Paniccia G; Campagna M; Bellino S; Meschiari M; Nozza S; Sighinolfi L; Latini A; Muscatello A; Saracino A; Di Pietro M; Galli M; Cafaro A; Magnani M; Ensoli F; Ensoli B
    Front Immunol; 2019; 10():233. PubMed ID: 30815001
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8
    Mota TM; McCann CD; Danesh A; Huang SH; Magat DB; Ren Y; Leyre L; Bui TD; Rohwetter TM; Kovacs CM; Benko E; MacLaren L; Wimpelberg A; Cannon CM; Hardy WD; Safrit JT; Jones RB
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission.
    Su H; Mueller A; Goldstein H
    Curr Opin HIV AIDS; 2024 Jul; 19(4):169-178. PubMed ID: 38695148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.
    Huang SH; Ren Y; Thomas AS; Chan D; Mueller S; Ward AR; Patel S; Bollard CM; Cruz CR; Karandish S; Truong R; Macedo AB; Bosque A; Kovacs C; Benko E; Piechocka-Trocha A; Wong H; Jeng E; Nixon DF; Ho YC; Siliciano RF; Walker BD; Jones RB
    J Clin Invest; 2018 Feb; 128(2):876-889. PubMed ID: 29355843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Controllers Exhibit Effective CD8
    Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD
    Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN
    J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Infection and Persistence in Pulmonary Mucosal Double Negative T Cells
    Meziane O; Salahuddin S; Pham TNQ; Farnos O; Pagliuzza A; Olivenstein R; Thomson E; Alexandrova Y; Orlova M; Schurr E; Ancuta P; Haddad É; Chomont N; Cohen EA; Jenabian MA; Costiniuk CT
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.
    Kamata M; Kim PY; Ng HL; Ringpis GE; Kranz E; Chan J; O'Connor S; Yang OO; Chen IS
    Biochem Biophys Res Commun; 2015 Jul; 463(3):216-21. PubMed ID: 25998390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.